Robert F. Kennedy Jr., the brand new Secretary of Well being and Human Providers, is reportedly set to satisfy with high executives from a number of main meals manufacturers on Monday.
This gathering marks the primary direct encounter between Kennedy and the businesses he’s publicly accused of contributing to People’ well being points, experiences POLITICO, citing sources conversant in the discussions.
Among the many anticipated attendees are senior leaders from Common Mills, Inc GIS and PepsiCo, Inc. PEP.
The dialogue comes on the request of the White Home, which has inspired Cupboard officers to have interaction with industries they oversee. Kennedy, a vocal critic of the meals trade, has lengthy blamed main meals conglomerates for fueling the rise of continual sicknesses in kids, the report provides.
Additionally Learn: Benzinga Bulls And Bears: Broadcom, ChargePoint, BigBear.ai — And Tariff Whiplash Confounds Markets
His “Make America Wholesome Once more” motion advocates for important adjustments to meals practices, equivalent to lowering meals dyes and banning sure chemical substances.
The assembly, which might be a pivotal second for each the trade and Kennedy’s agenda, will deal with issues equivalent to eliminating seed oils, banning components, and the FDA’s new plans for diet labels, POLITICO additional notes.
Meals corporations have expressed alarm over Kennedy’s proposals, significantly his stance on ultra-processed meals and his push for stricter laws on components.
Moreover, the U.S. Division of Well being and Human Providers and the Division of Agriculture are anticipated to finalize the following Dietary Pointers for People, offering one other alternative for the meals trade to sway key selections on diet and public well being.
The assembly’s agenda stays unsure, with some trade gamers expressing issues about potential conflicts over the route of the discussions.
Learn Subsequent:
Momentum27.21
Progress28.83
High quality36.17
Worth34.97
Market Information and Knowledge delivered to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.